FCM
ALT icon

Farallon Capital Management’s Altimmune ALT Stock Holding History

Farallon Capital Management’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$85K Hold
27,600
– – ﹤0.01% 162
2025
Q4 		$99.6K Hold
27,600
– – ﹤0.01% 145
2025
Q3 		$104K Hold
27,600
– – ﹤0.01% 135
2025
Q2 		$107K Hold
27,600
– – ﹤0.01% 129
2025
Q1 		$138K Hold
27,600
– – ﹤0.01% 129
2024
Q4 		$199K Hold
27,600
– – ﹤0.01% 130
2024
Q3 		$169K Hold
27,600
– – ﹤0.01% 147
2024
Q2 		$184K Sell
27,600
-442,400
-94% -$3.26M ﹤0.01% 143
2024
Q1 		$4.78M Buy
470,000
+436,000
+1,282% +$4.43M 0.02% 102
2023
Q4 		$383K Buy
+34,000
New +$142K ﹤0.01% 114

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Farallon Capital Management's ALT Position: Q1 2026 in Review

Farallon Capital Management held its Altimmune (ALT) position steady in Q1 2026 at 27,600 shares worth $85K. The position accounts for ﹤0.01% of the portfolio, ranked #162.

Farallon Capital Management first reported a position in ALT in Q4 2023 and has held it in 10 quarters since. The position peaked at $4.78M in Q1 2024. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Farallon Capital Management held 27,600 shares of Altimmune worth $85K as of Q1 2026.
  • Farallon Capital Management left its Altimmune share count unchanged in Q1 2026.
  • Altimmune made up ﹤0.01% of Farallon Capital Management's portfolio in Q1 2026, its #162 holding.
  • Farallon Capital Management first reported a position in Altimmune in Q4 2023 and has held it in 10 quarters since.
  • Farallon Capital Management's Altimmune position peaked at $4.78M in Q1 2024.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Farallon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.